These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36103616)

  • 1. Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy.
    Yadav P; Dua C; Bajaj A
    Chem Rec; 2022 Dec; 22(12):e202200152. PubMed ID: 36103616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Targeting H
    Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
    ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer.
    Khafaga AF; Gaballa MMS; Karam R; Shoulah SA; Shamma RN; Khalifa NE; Farrag NE; Noreldin AE
    Life Sci; 2024 Mar; 341():122499. PubMed ID: 38342375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
    Rajabi M; Adeyeye M; Mousa SA
    Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials.
    Liu C; Zhang T; Chen L; Chen Y
    Cancer Lett; 2020 Sep; 487():45-52. PubMed ID: 32474154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
    Dutta B; Barick KC; Hassan PA
    Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenesis for cancer: Current status and prospects.
    Russo M; Giavazzi R
    Thromb Res; 2018 Apr; 164 Suppl 1():S3-S6. PubMed ID: 29703482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions.
    Lin Z; Zhang Q; Luo W
    Eur J Pharmacol; 2016 Dec; 793():76-81. PubMed ID: 27840192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic anticancer strategy based on nanoparticulate systems.
    Yoncheva K; Momekov G
    Expert Opin Drug Deliv; 2011 Aug; 8(8):1041-56. PubMed ID: 21585229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
    Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
    Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.
    You YH; Lin YF; Nirosha B; Chang HT; Huang YF
    Nanotheranostics; 2019; 3(3):266-283. PubMed ID: 31263658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
    Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.